Louisiana State Employees Retirement System Acquires New Shares in Astrana Health, Inc. $ASTH

Louisiana State Employees Retirement System bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 19,100 shares of the company’s stock, valued at approximately $468,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ASTH. Royal Bank of Canada raised its holdings in shares of Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after purchasing an additional 17,028 shares in the last quarter. AQR Capital Management LLC bought a new position in shares of Astrana Health during the first quarter valued at approximately $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after purchasing an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the period. Finally, Intech Investment Management LLC increased its holdings in Astrana Health by 5.8% during the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after buying an additional 2,462 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ASTH has been the subject of a number of analyst reports. Needham & Company LLC upped their target price on Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a report on Friday, May 8th. TD Cowen lifted their price target on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Robert W. Baird set a $45.00 price target on Astrana Health in a research report on Friday, May 8th. Truist Financial upped their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Finally, Weiss Ratings raised Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 1st. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Trading Down 1.6%

NASDAQ:ASTH opened at $46.28 on Thursday. Astrana Health, Inc. has a 52 week low of $18.08 and a 52 week high of $51.60. The firm has a 50 day moving average of $39.85 and a 200 day moving average of $30.21. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $2.58 billion, a price-to-earnings ratio of 75.87 and a beta of 0.89.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The business had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. During the same period in the prior year, the firm posted $0.42 earnings per share. The business’s quarterly revenue was up 55.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.